+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention



Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention



Journal of Clinical Investigation 103(9): 1237-1241




(PDF emailed within 1 workday: $29.90)

Accession: 010961145

Download citation: RISBibTeXText

PMID: 10225966


Related references

Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease. Current Pharmaceutical Design 13(17): 1787-1802, 2007

Matrix Metalloproteinases: New Routes to the Use of Mt1-Mmp As A Therapeutic Target in Angiogenesis-Related Disease. Current Pharmaceutical Design 13(17): 1787-1802, 2007

Review of Three New Agents That Target Angiogenesis, Matrix Metalloproteinases, and Cyclin-Dependent Kinases. Cancer Control 6(5): 459-465, 2000

Matrix metalloproteinases: a potential therapeutic target in atherosclerosis. Current Drug Targets. Cardiovascular and Haematological Disorders 5(6): 541-548, 2006

Matrix metalloproteinases: a therapeutic target in cardiovascular disease. Current Pharmaceutical Design 9(13): 1033-1040, 2003

Matrix Metalloproteinases: A Potential Therapeutic Target in Atherosclerosis. Current Drug Targets - Cardiovascular & Haematological Disorders 5(6): 541-548, 2005

Matrix metalloproteinases and coronary artery disease: a novel therapeutic target. Journal of Clinical Pharmacology 37(11): 991-1000, 1998

Matrix metalloproteinases in vascular disease--a potential therapeutic target?. Current Vascular Pharmacology 8(1): 75-85, 2010

Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?. Current Vascular Pharmacology 8(1): 75-85, 2010

Matrix Metalloproteinases and Coronary Artery Disease: A Novel Therapeutic Target. The Journal of Clinical Pharmacology 37(11): 991-1000, 1997

Matrix metalloproteinases in acute coronary syndromes: a new therapeutic target?. International Journal of Cardiology 134(3): 402-404, 2008

Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer. Methods in Molecular Biology 1731: 325-348, 2018

Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain. Expert Opinion on Therapeutic Targets 19(2): 177-185, 2015

Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target. Journal of Clinical Pharmacology 38(12): 1077-1088, 2001

Matrix metalloproteinases: potential therapeutic target in spinal cord injury. Clinical Chemistry and Laboratory Medicine 39(4): 362-367, 2001